ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3090 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3090; 2) Community: the network communities that were significantly associated with the response to NSC 3090; 3) Molecule: the relationships between components within communities and NSC 3090; 4) MDR: the compounds that were significantly associated with the NSC 3090.

NSC Compound Enrichment Correlation
NSC 757949 (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0410413740044188 -0.041323371
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0410413740044188 0.3301004
NSC 123111 Mitomycin derivative T 53 0.0423559437159349 0.28295061
NSC 143647 Propionic acid, 2-amino-3-(hydroxynitrosamino)-, DL- (8CI) 0.0423559437159349 0.25375335
NSC 155594 Null 0.0423559437159349 0.3923606
NSC 318800 Uridine, 5-fluoro-, 2',3',5'-triacetate 0.0423559437159349 0.080993893
NSC 627687 Null 0.0423559437159349 0.50818512
NSC 627771 4-Aza-2'-phenyl-5.alpha.-cholestano[3,2-c]pyrazole 0.0423559437159349 0.155415
NSC 658228 Null 0.0423559437159349 0.23527908
NSC 665713 Null 0.0423559437159349 0.15543193
Total:86  Current:80    [First] [Prev] [Next] [Last]